[go: up one dir, main page]

Latest News for: bge

Edit

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, ...

Nasdaq Globe Newswire 16 Jun 2026
Randomized, double-blind, placebo-controlled, dose-ranging trial evaluating three once-daily oral doses of BGE-102 in participants with elevated systemic inflammation and additional cardiovascular risk factors ... .
Edit

ADA2026: Oral NLRP3 Inhibitor BGE-102 Preserves Retinal Vascular Integrity in a Preclinical Model of Diabetic Retinopathy (Bioage Labs Inc)

Public Technologies 09 Jun 2026
Oral NLRP3 Inhibitor BGE-102 Preserves Retinal Vascular Integrity in a Preclinical Model of Diabetic Retinopathy ... BGE-102 long treatment for up to 14 wks ... BGE-102 (20 mpk) ... BGE-102 (50 mpk) ... BGE-102 (20 mpk) ... BGE-102 (50 mpk).
Edit

ADA2026: BGE-102, a Novel NLRP3 Inhibitor, Demonstrated Robust Anti-Inflammatory Activity in a Phase 1 Study in Healthy Volunteers and Participants with Obesity (Bioage Labs Inc)

Public Technologies 09 Jun 2026
BGE-102, a Novel NLRP3 Inhibitor, Demonstrated Robust Anti-Inflammatory Activity in a Phase 1 Study in Healthy Volunteers and Participants with Obesity ... BGE-102 60 mg QD ... BGE-102 60 mg QD ... BGE-102 120 mg QD ... BGE-102 120 mg QD ... All BGE-102 ... BGE-102.
Edit

Baltimore bridge collapse: BGE utility, final family settle with Dali owners ahead of court fight

The Daily Gazette 30 May 2026
BALTIMORE — As the final victim’s family and utility company BGE settled claims with the Dali’s owners Friday over the Francis Scott Key Bridge collapse, a larger courtroom battle is about to begin. whether the companies behind the ship can ... .
Edit

BGE, Delmarva Power and Pepco Joint Statement on Megawatts for Maryland (Exelon Corporation)

Public Technologies 27 May 2026
) ... We agree with the governor. to meet rising demand for energy in Maryland, the state needs everyone at the table ... Attachments Original document Permalink. Disclaimer ... (noodl. 132042342) .
×